Allogene Therapeutics Inc (ALLO)
NASDAQ:ALLO
US Market

Allogene Therapeutics (ALLO) Similar Stocks

1,245 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Allogene Therapeutics
$607.56M
-1.62
-42.49%
10 Buy
2 Hold
0 Sell
Strong Buy
$12.70
Adaptimmune Therapeutics
$332.14M
-1.78
39.78%
4 Buy
2 Hold
1 Sell
Moderate Buy
$2.28
Arcturus Therapeutics
$618.89M
-5.88
-33.83%
7 Buy
0 Hold
0 Sell
Strong Buy
$78.50
Crispr Therapeutics AG
$4.89B
-21.15
0.51%
9 Buy
6 Hold
2 Sell
Moderate Buy
$75.13
Sangamo Biosciences
$139.45M
-0.36
-50.00%
3 Buy
1 Hold
0 Sell
Strong Buy
$3.33

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
ALLO
Allogene Therapeutics
2.91
-1.82
-38.48%
ADAP
Adaptimmune Therapeutics
1.30
0.43
49.43%
ARCT
Arcturus Therapeutics
22.98
-10.53
-31.42%
CRSP
Crispr Therapeutics AG
57.57
2.13
3.84%
SGMO
Sangamo Biosciences
0.67
-0.54
-44.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis